• Product information
  • Downloads

GENERAL INFORMATION

An Inside Out Approach to Prostate Ablation

Profound Medical is a Canadian medical device company that has developed a unique and minimally invasive procedure to ablate targeted prostate tissue.

Profound’s novel technology, TULSA, combines real-time MR imaging with transurethral therapeutic ultrasound and closed-loop thermal feedback control. It provides a highly precise treatment tailored to patient-specific anatomy and pathology. This method of prostate ablation offers short treatment times and low morbidity, allowing for fast patient recovery.

12-month results of the TULSA-PROTM Phase 1 Clinical Trial published in European Urology (http://bit.ly/1O7LVcv) demonstrated clinical safety and precision of TULSA-PRO for near whole-gland prostate ablation, with low toxicity and a well-tolerated safety profile. Profound Medical continues to monitor the initial 30 patients for 5 years.

A 110 patient Pivotal Trial is being established in over 10 institutions in Europe (Germany, Spain, The Netherlands), Canada and the United States.

 

Technical specifications

Questions to the product

Contact MEMED CZ
MeMed CZ s.r.o.
Dukelská 5779
430 01 Chomutov
Czech Republic
+420 777 333 452
office@memed.cz
Google Maps Location
Technical Service-Hotline
+420 774 891 207
office@memed.cz

Mo - Fr from 7:00 to 15:00